REGULATION

While financial investment in novel therapies provides patients with new care options and often improved quality of care, the Avaltus Pharmaceutical also recognizes the significance of its responsibility to manage the perceived potential conflict of interest where profits rather than patients' welfare is the priority. To maintain this balance, the industry employs leading scientific researchers and clinicians, and collaborates with outside medical experts and professional organizations from the preclinical period through introduction of the product and beyond. Industry collaboration with experts in the field works to ensure that patients have access to the most current therapy options available through physicians who support the use of these new therapies. Medical experts also help to establish the appropriate usage of new therapies by gaining clinical experience with these drugs, which also serves to protect patient safety as far as possible.